Christopher Rhodes to Treatment Outcome
This is a "connection" page, showing publications Christopher Rhodes has written about Treatment Outcome.
Connection Strength
0.143
-
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension. Circulation. 2017 01 31; 135(5):460-475.
Score: 0.060
-
Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011 Jul; 97(13):1054-60.
Score: 0.041
-
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension. Eur Respir J. 2022 03; 59(3).
Score: 0.022
-
Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover Trials. Ann Am Thorac Soc. 2021 06; 18(6):981-988.
Score: 0.021